TABLE 4.
Summary of studies focussing on referral filtering schemes, grouped based on outcomes assessed.
| Focus | Author(s) | Year | Location |
|---|---|---|---|
| Cost assessment | Forbes et al.25 | 2019 | UK |
| Mason et al.28 | 2017 | UK | |
| Acceptability | Barrett and Loughman29 | 2018 | Ireland |
| Baker et al.30 | 2016 | UK | |
| Konstantakopoulou et al.31 | 2014 | UK | |
| Clinical impact | Kanabar et al.32 | 2021 | UK |
| Huang et al.33 | 2020 | Australia | |
| Phu et al.34 | 2020 | Australia | |
| Gunn et al.35 | 2019 | UK | |
| Bowes et al.36 | 2018 | UK | |
| Konstantakopoulou et al.37 | 2018 | UK | |
| Ly et al.38 | 2017 | Australia | |
| Ly et al.39 | 2016 | Australia | |
| McAlinden et al.40 | 2016 | UK | |
| El-Assal et al.41 | 2015 | UK | |
| Roberts et al.42 | 2015 | UK | |
| Keenan et al.43 | 2015 | UK | |
| Ratnarajan et al.44 | 2015 | UK | |
| Ratnarajan et al.45 | 2013a | UK | |
| Bourne et al.46 | 2010 | UK | |
| Park et al.47 | 2009 | UK | |
| Ang et al.48 | 2009 | UK | |
| Lash et al.49 | 2006 | UK | |
| Mixed focus | Wang et al.50 | 2021 | Australia |
| Ford et al.51 | 2019 | Australia | |
| Konstantakopoulou et al.52 | 2016 | UK | |
| Ratnarajan et al.53 | 2013b | UK | |
| Devarajan et al.54 | 2011 | UK | |
| Parkins and Edgar55 | 2011 | UK | |
| Syam et al.56 | 2010 | UK | |
| Sheen et al.57 | 2009 | UK | |
| Henson et al.58 | 2003 | UK |